Related Experiment Video
Updated: Jun 15, 2025

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
Video-Based Directly Observed Therapy (ViDOT) as a Strategic Tool to Improve Medication Adherence in Epilepsy: A
Paul Olowoyo1,2, Olabode Oguntiloye3, Luqman Ogunjimi4
1Department of Medicine, Afe Babalola University, Ado-Ekiti, Nigeria.
Video-based Directly Observed Therapy (ViDOT) can improve epilepsy treatment adherence in Central Africa by leveraging smartphones. This mHealth approach addresses challenges like poor drug adherence and limited access to care, promoting better health outcomes.
Area of Science:
- Neurology
- Public Health
- Digital Health
Background:
- Epilepsy prevalence is highest in Central Africa, particularly in rural areas, exacerbated by treatment gaps and poor infrastructure.
- Poor drug adherence and limited access to specialized care are significant challenges for epilepsy management in the region.
Purpose of the Study:
- To review the literature on Video-based Directly Observed Therapy (ViDOT) for chronic diseases, focusing on its application in improving epilepsy care.
- To assess the potential of ViDOT in addressing drug adherence challenges in epilepsy patients.
Main Methods:
- A narrative review of existing literature was conducted using PubMed and Google Scholar.
- Relevant publications on ViDOT and chronic diseases, specifically epilepsy, were identified and assessed.
Main Results:
- Poor drug adherence is a major risk factor for adverse outcomes in epilepsy patients.
- ViDOT shows potential to significantly improve drug adherence, reduce waiting times, enhance access to care, and decrease stigma.
- Potential benefits also include reduced neurologist workload and cost-effectiveness, though network coverage is a challenge.
Conclusions:
- Psychoeducation on epilepsy and anti-epileptic drugs (AEDs) is crucial for improving adherence.
- ViDOT offers a promising mHealth solution for disseminating vital information to epilepsy patients and caregivers, promoting better health outcomes.
More Related Videos
04:51Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
Published on: April 11, 2019
05:54Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
Related Concept Videos
Drug Therapy
Antianxiety Medications
Electroconvulsive Therapy
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...